Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats

Richard J. Briscoe, Camilo L. Cabrera, Theodore J. Baird, Kenner C. Rice, James H. Woods

Resultado de la investigación: Articlerevisión exhaustiva

46 Citas (Scopus)

Resumen

Central administration of CRH results in endocrinological, cardiovascular, and behavioral effects that suggest stress or anxiety. Among these is a marked pressor response. Parenteral administration of CRH, however, results in hypotension. We used parenteral administration of antalarmin, a novel, small molecule CRH1 receptor antagonist, and α-helical CRH9-41, a peptidic CRHR1/CRHR2 antagonist to attempt to determine the receptor mechanisms through which CRH is acting in both of these situations. Our results suggest that the hypertension produced by central CRH administration is mediated through central CRHR1 receptors, whereas the hypotension produced by parenteral CRH administration is mediated through peripheral CRHR2 receptors. Copyright (C) 2000 Elsevier Science B.V.

Idioma originalEnglish (US)
Páginas (desde-hasta)204-207
Número de páginas4
PublicaciónBrain Research
Volumen881
N.º2
DOI
EstadoPublished - oct. 27 2000
Publicado de forma externa

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Huella

Profundice en los temas de investigación de 'Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats'. En conjunto forman una huella única.

Citar esto